Patient support / hub services continue to evolve
The goal of producing meaningful data is driving industry progress
FDA warns CanaRx, a Canadian “pharmacy” serving the US market
Agency tries to get a handle on cross-border trade
Eversana fills out its management team with more industry leaders
Ex-AmerisourceBergen, -Cardinal and -inVentiv Health execs join team
Include the sales force in incentive compensation
By working with the sales force, incentive plan design can boost a product launch
McKesson gets called out by FDA for alleged DSCSA violations
Issues include apparently diverted opioids and mislabeled medications
Biomarkers drive advances in drug therapy
As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization
NFC label provides patient guidance and reporting for autoinjector
Smart tag connects onboard intelligence with smartphone
FDA pilot program for DSCSA compliance kicks off
30-day deadline for making an application to participate; in the EU, the FMD program is progressing
New hub services provider opens its doors
Diligent Health Solutions banks on experienced management
Trump Administration gears up its drug-pricing campaign
Will restricting use of rebates in federal programs carry over to commercial insurance?
Sanofi Pasteur gains approval for more Tdap indications
A marketing challenge: how to make more adults aware of anti-bacterial booster shots
Cold chain capacity concerns around the world
Expansions in the capability of supply chain participants to manage temperature-controlled pharmaceuticals
Want Congressional bipartisanship? Talk about cutting drug prices!
Senate and House committees begin the legislative process for addressing drug pricing
Global pharma spending will hit $1.5 trillion in 2023, says IQVIA
Annual analysis predicts 3-6% CAGR through 2023, a lower rate than 2014-2018
Cellular and genetic therapies push into the commercial arena
Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost
Savsu Technologies offers new CGT transport containers
Broader capabilities for refrigerated or cryogenic transport of cellular materials
ZappRx builds out more disease-specific prior-authorization programs
Signs up Bayer Health for pulmonary hypertension and MS
DSCSA compliance: Industry is still in the trenches
Nov. 27, 2018, was to be a red-letter day in the 10-year program to implement an end-to-end pharma traceability system. Did industry meet the deadline?
New PAP programs for HIV, migraine, bladder cancer and an enzyme deficiency
Programs provide copay and other financial assistance
Poseidon network advances its pharmaceutical ocean-freight initiative
Field trial results to be unveiled at upcoming meeting
Cryoport expands its sources of temperature-controlled logistics solutions
Partnership with Dacos A/S; FDA will look closer at cellular and genetic therapies
Dartmouth academics look at 20 years of medical marketing
Spending on drug promotion rose—but not at the rate of pharma sales growth
Prescription digital therapeutics are entering the healthcare mainstream
Sandoz and Pear Therapeutics tackle opioid use disorder
Antares Vision recapitalizes with a $80-million investment by Mediobanca
Strengthening a leading player in track-and-trace packaging technology
BMS offers $74 billion to acquire Celgene
A deeper commitment to oncology and immunology
FROM PRMA CONSULTING
FDA set an all-time record of new drug approvals in 2018
List includes 25 orphan drugs; there were also seven additional biosimilars
Here comes the 2018-19 US flu season
Flu activity is “elevated” nationally; Walgreens sees a hotspot in Nebraska
HIV/AIDS treatment: Improving the trajectory for all stakeholders
Nearly a million US citizens live with HIV, a virus that still lacks a curative therapy
The scramble to ramp up CGT production
Cellular and genetic therapies (CGTs) developers are struggling to build capacity
